Literature DB >> 29500733

Profiling of Germline Mutations in Major Hotspot Codons of TP53 Using PCR-RFLP.

B H Giridhar1, S Vishwanath2, Anirban Chakraborty3.   

Abstract

Tumor suppressor protein, TP53 also known as the "guardian of the genome" plays a key role in preventing malignant transformation. Almost 50% of human tumors carry mutations in this gene; in the remaining tumors, the TP53 network is functionally inoperative. The majority of TP53 mutations are missense mutations and more than 90% of the missense mutations affect specific codons in the DNA-binding domain, called "hotspot codons." The present study was aimed at analyzing the germline mutation status of four hotspot codons in TP53 namely, codon 175, codon 245, codon 248 (within the DNA binding domain) and codon 72 (outside the DNA binding domain) in cancer cases encountered in a tertiary care hospital in South India by PCR-RFLP. The case-control study included 85-10 subjects respectively. The results of the study indicated that majority of the cancer cases did not harbor germline mutations in the four hot spot codons of TP53. The study further highlights the usefulness of PCR-RFLP as a simple and cost effective tool for checking gene mutations.

Entities:  

Keywords:  Cancer; Heteroallelic mutation; Homoallelic mutation; Hotspot codon; Mutation; Tumor suppressor protein TP53

Mesh:

Substances:

Year:  2018        PMID: 29500733     DOI: 10.1007/s12253-018-0394-8

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  16 in total

Review 1.  Guarding the 'translation apparatus': defective ribosome biogenesis and the p53 signaling pathway.

Authors:  Anirban Chakraborty; Tamayo Uechi; Naoya Kenmochi
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-01-20       Impact factor: 9.957

2.  T antigen is bound to a host protein in SV40-transformed cells.

Authors:  D P Lane; L V Crawford
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

Review 3.  Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.

Authors:  A Sigal; V Rotter
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

Review 4.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

5.  Mutations in the p53 gene occur in diverse human tumour types.

Authors:  J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; N Davidson; S Baylin; P Devilee
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

6.  Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells.

Authors:  D I Linzer; A J Levine
Journal:  Cell       Date:  1979-05       Impact factor: 41.582

Review 7.  p53 Antibodies in the sera of patients with various types of cancer: a review.

Authors:  T Soussi
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

8.  Prevalence of aflatoxin induced p53 mutation at codon 249 (R249s) in hepatocellular carcinoma patients with and without hepatitis B surface antigen (HBsAg).

Authors:  Salyavit Chittmittrapap; Thaweesak Chieochansin; Roongruedee Chaiteerakij; Sombat Treeprasertsuk; Naruemon Klaikaew; Pisit Tangkijvanich; Piyawat Komolmit; Yong Poovorawan
Journal:  Asian Pac J Cancer Prev       Date:  2013

Review 9.  Awakening guardian angels: drugging the p53 pathway.

Authors:  Christopher J Brown; Sonia Lain; Chandra S Verma; Alan R Fersht; David P Lane
Journal:  Nat Rev Cancer       Date:  2009-12       Impact factor: 60.716

10.  "Hot spots" mutation analysis of p53 gene in gastrointestinal cancers by amplification of naturally occurring and artificially created restriction sites.

Authors:  P H Chen; S Y Lin; C K Wang; Y J Chen; T C Chen; J G Chang
Journal:  Clin Chem       Date:  1993-10       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.